133 related articles for article (PubMed ID: 10573133)
1. The prognostic value of in vitro cultures of erythroid and megakaryocyte progenitors in myelodysplastic syndromes.
Juvonen E; Aimolahti A; Volin L; Ruutu T
Leuk Res; 1999 Oct; 23(10):889-94. PubMed ID: 10573133
[TBL] [Abstract][Full Text] [Related]
2. Megakaryocyte, erythroid and granulocyte-macrophage colony formation in myelodysplastic syndromes.
Dan K; An E; Futaki M; Inokuchi K; Gomi S; Yamada T; Ogata K; Tanabe Y; Ohki I; Shinohara T
Acta Haematol; 1993; 89(3):113-8. PubMed ID: 8362599
[TBL] [Abstract][Full Text] [Related]
3. Blast colony-forming cells in myelodysplastic syndrome: decreased potential to generate erythroid precursors.
Backx B; Broeders L; Touw I; Löwenberg B
Leukemia; 1993 Jan; 7(1):75-9. PubMed ID: 8418382
[TBL] [Abstract][Full Text] [Related]
4. Biological and clinical significance of clonogenic assays in patients with myelodysplastic syndromes.
Marisavljević D; Rolović Z; Sefer D; Basara N; Ilić D; Bosković D; Colović M
Med Oncol; 2002; 19(4):249-59. PubMed ID: 12512919
[TBL] [Abstract][Full Text] [Related]
5. Effect of in vivo treatment with rh GM-CSF on in vitro growth of haematopoietic progenitors in patients with myelodysplastic syndromes.
Visani G; Tosi P; Finelli C; Gamberi B; Zauli G; Cenacchi A; Fogli M; Colombini R; Tura S
Haematologica; 1992; 77(2):142-5. PubMed ID: 1383105
[TBL] [Abstract][Full Text] [Related]
6. Abnormal megakaryopoiesis in patients with myelodysplastic syndromes: analysis of cellular and humoral defects.
Geissler D; Zwierzina H; Pechlaner C; Gaggl S; Schmalzl F; Konwalinka G; Braunsteiner H
Br J Haematol; 1989 Sep; 73(1):29-35. PubMed ID: 2679861
[TBL] [Abstract][Full Text] [Related]
7. Mast cell growth factor (c-kit ligand) restores growth of multipotent progenitors in myelodysplastic syndrome.
Glinsmann-Gibson B; Spier C; Baier M; Taetle R; Broudy VC; List AF
Leukemia; 1994 May; 8(5):827-32. PubMed ID: 7514248
[TBL] [Abstract][Full Text] [Related]
8. Growth of human hematopoietic colonies from patients with myelodysplastic syndromes in response to recombinant human granulocyte-macrophage colony-stimulating factor.
Carlo-Stella C; Cazzola M; Bergamaschi G; Bernasconi P; Dezza L; Invernizzi R; Pedrazzoli P
Leukemia; 1989 May; 3(5):363-6. PubMed ID: 2654496
[TBL] [Abstract][Full Text] [Related]
9. Colony formation by megakaryocyte progenitors in myelodysplatic syndromes.
Juvonen E; Partanen S; Knuutila S; Ruutu T
Eur J Haematol; 1989 Apr; 42(4):389-95. PubMed ID: 2721661
[TBL] [Abstract][Full Text] [Related]
10. [Analysis of in vitro characteristics of colony-forming cells in myelodysplastic syndrome and comparison with that in non-severe aplastic anemia].
Zhang TJ; Feng M; Zheng YZ; Li XX; Xu ZF; Qin TJ; Zhang Y; Yang YB; Liu JX; Ren YS; Xiao ZJ
Zhonghua Xue Ye Xue Za Zhi; 2012 Jul; 33(7):516-21. PubMed ID: 22967409
[TBL] [Abstract][Full Text] [Related]
11. Increase in peripheral blood megakaryocyte progenitors following cancer therapy with high-dose cyclophosphamide and hematopoietic growth factors.
Siena S; Bregni M; Bonsi L; Sklenar I; Bagnara GP; Bonadonna G; Gianni AM
Exp Hematol; 1993 Nov; 21(12):1583-90. PubMed ID: 7691640
[TBL] [Abstract][Full Text] [Related]
12. Stem cell factor improvement of proliferation and maintenance of hemopoietic progenitors in myelodysplastic syndromes.
Piacibello W; Sanavio F; Bresso P; Severino A; Carlesso N; Pregno P; Stacchini A; Morelli S; Fubini L; Gallo E
Leukemia; 1994 Feb; 8(2):250-7. PubMed ID: 7508532
[TBL] [Abstract][Full Text] [Related]
13. Effect of culture conditions on in vitro erythroid colony formation in myelodysplastic syndromes.
Juvonen E; Ruutu T
Exp Hematol; 1990 Nov; 18(10):1070-2. PubMed ID: 2209760
[TBL] [Abstract][Full Text] [Related]
14. Thrombopoietin stimulates myelodysplastic syndrome granulocyte-macrophage and erythroid progenitor proliferation.
Ferrajoli A; Talpaz M; Kurzrock R; Harris D; Van Q; Estey EH; Estrov Z
Leuk Lymphoma; 1998 Jul; 30(3-4):279-92. PubMed ID: 9713960
[TBL] [Abstract][Full Text] [Related]
15. Erythroid and granulocyte-macrophage colony formation in myelodysplastic syndromes.
Ruutu T; Partanen S; Lintula R; Teerenhovi L; Knuutila S
Scand J Haematol; 1984 Apr; 32(4):395-402. PubMed ID: 6719044
[TBL] [Abstract][Full Text] [Related]
16. Growth characteristics of circulating hematopoietic progenitor cells from patients with essential thrombocythemia.
Mazur EM; Cohen JL; Bogart L
Blood; 1988 Jun; 71(6):1544-50. PubMed ID: 3259440
[TBL] [Abstract][Full Text] [Related]
17. All-trans retinoic acid potentiates megakaryocyte colony formation: in vitro and in vivo effects after administration to acute promyelocytic leukemia patients.
Visani G; Zauli G; Tosi P; Ottaviani E; Gibellini D; Manfroi S; Celeghini C; Pagliarini C; Bassini A; Tura S
Leukemia; 1994 Dec; 8(12):2183-7. PubMed ID: 7528859
[TBL] [Abstract][Full Text] [Related]
18. Bone marrow cultures in dysmyelopoietic syndrome: diagnostic and prognostic evaluation.
Shihab-el-Deen A; Guevara C; Prchal JF
Acta Haematol; 1987; 78(1):17-22. PubMed ID: 3116803
[TBL] [Abstract][Full Text] [Related]
19. Effect of interleukin-1, GM-CSF, erythropoietin, and lithium on the toxicity associated with 3'-azido-3'-deoxythymidine (AZT) in vitro on hematopoietic progenitors (CFU-GM, CFU-MEG, and BFU-E) using murine retrovirus-infected hematopoietic cells.
Gallicchio VS; Hughes NK; Hulette BC; Noblitt L
J Leukoc Biol; 1991 Dec; 50(6):580-6. PubMed ID: 1940611
[TBL] [Abstract][Full Text] [Related]
20. In vitro growth of bone marrow-derived multipotent and lineage-restricted hematopoietic progenitor cells in myelodysplastic syndromes.
Carlo-Stella C; Cazzola M; Bernasconi P; Bergamaschi G; Dezza L; Pedrazzoli P; Rosti V; Tomaselli S; Zappone E
Haematologica; 1989; 74(2):181-6. PubMed ID: 2501171
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
